ATC code M01
ATC code M01 Anti-inflammatory and antirheumatic products is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup M01 is part of the anatomical group M Musculo-skeletal system.[4]
| ATC code M: Musculo-skeletal system |
|---|
|
| Other ATC codes |
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QM01.[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
M01A Anti-inflammatory and antirheumatic products, non-steroids
M01AA Butylpyrazolidines
- M01AA01 Phenylbutazone
- M01AA02 Mofebutazone
- M01AA03 Oxyphenbutazone
- M01AA05 Clofezone
- M01AA06 Kebuzone
- QM01AA90 Suxibuzone
- QM01AA99 Combinations
M01AB Acetic acid derivatives and related substances
- M01AB01 Indometacin
- M01AB02 Sulindac
- M01AB03 Tolmetin
- M01AB04 Zomepirac
- M01AB05 Diclofenac
- M01AB06 Alclofenac
- M01AB07 Bumadizone
- M01AB08 Etodolac
- M01AB09 Lonazolac
- M01AB10 Fentiazac
- M01AB11 Acemetacin
- M01AB12 Difenpiramide
- M01AB13 Oxametacin
- M01AB14 Proglumetacin
- M01AB15 Ketorolac
- M01AB16 Aceclofenac
- M01AB17 Bufexamac
- M01AB51 Indometacin, combinations
- M01AB55 Diclofenac, combinations
M01AC Oxicams
- M01AC01 Piroxicam
- M01AC02 Tenoxicam
- M01AC04 Droxicam
- M01AC05 Lornoxicam
- M01AC06 Meloxicam
- M01AC56 Meloxicam, combinations
M01AE Propionic acid derivatives
- M01AE01 Ibuprofen
- M01AE02 Naproxen
- M01AE03 Ketoprofen
- M01AE04 Fenoprofen
- M01AE05 Fenbufen
- M01AE06 Benoxaprofen
- M01AE07 Suprofen
- M01AE08 Pirprofen
- M01AE09 Flurbiprofen
- M01AE10 Indoprofen
- M01AE11 Tiaprofenic acid
- M01AE12 Oxaprozin
- M01AE13 Ibuproxam
- M01AE14 Dexibuprofen
- M01AE15 Flunoxaprofen
- M01AE16 Alminoprofen
- M01AE17 Dexketoprofen
- M01AE18 Naproxcinod
- M01AE51 Ibuprofen, combinations
- M01AE52 Naproxen and esomeprazole
- M01AE53 Ketoprofen, combinations
- M01AE56 Naproxen and misoprostol
- QM01AE90 Vedaprofen
- QM01AE91 Carprofen
- QM01AE92 Tepoxalin
M01AG Fenamates
- M01AG01 Mefenamic acid
- M01AG02 Tolfenamic acid
- M01AG03 Flufenamic acid
- M01AG04 Meclofenamic acid
- QM01AG90 Flunixin
M01AH Coxibs
- M01AH01 Celecoxib
- M01AH02 Rofecoxib
- M01AH03 Valdecoxib
- M01AH04 Parecoxib
- M01AH05 Etoricoxib
- M01AH06 Lumiracoxib
- M01AH07 Polmacoxib
- QM01AH90 Firocoxib
- QM01AH91 Robenacoxib
- QM01AH92 Mavacoxib
- QM01AH93 Cimicoxib
- QM01AH94 Deracoxib
- QM01AH95 Enflicoxib
M01AX Other anti-inflammatory and antirheumatic agents, non-steroids
- M01AX01 Nabumetone
- M01AX02 Niflumic acid
- M01AX04 Azapropazone
- M01AX05 Glucosamine
- M01AX07 Benzydamine
- M01AX12 Glucosaminoglycan polysulfate
- M01AX13 Proquazone
- M01AX14 Orgotein
- M01AX17 Nimesulide
- M01AX18 Feprazone
- M01AX21 Diacerein
- M01AX22 Morniflumate
- M01AX23 Tenidap
- M01AX24 Oxaceprol
- M01AX25 Chondroitin sulfate
- M01AX26 Avocado and soybean oil, unsaponifiables
- QM01AX52 Niflumic acid, combinations
- M01AX68 Feprazone, combinations
- QM01AX90 Pentosan polysulfate
- QM01AX91 Aminopropionitrile
- QM01AX92 Grapiprant
- QM01AX99 Combinations
M01B Anti-inflammatory/antirheumatic agents in combination
M01BA Anti-inflammatory/antirheumatic agents in combination with corticosteroids
- M01BA01 Phenylbutazone and corticosteroids
- M01BA02 Dipyrocetyl and corticosteroids
- M01BA03 Acetylsalicylic acid and corticosteroids
- QM01BA99 Combinations
M01C Specific antirheumatic agents
M01CA Quinolines
- M01CA03 Oxycinchophen
M01CB Gold preparations
- M01CB01 Sodium aurothiomalate
- M01CB02 Sodium aurothiosulfate
- M01CB03 Auranofin
- M01CB04 Aurothioglucose
- M01CB05 Aurotioprol
M01CC Penicillamine and similar agents
- M01CC01 Penicillamine
- M01CC02 Bucillamine
References
- "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- "ATC/DDD Index 2022: code M01". WHO Collaborating Centre for Drug Statistics Methodology.
- "ATCvet Index 2022: code QM01". WHO Collaborating Centre for Drug Statistics Methodology.
| pyrazolones / pyrazolidines | |
|---|---|
| salicylates | |
| acetic acid derivatives and related substances | |
| oxicams |
|
| propionic acid derivatives (profens) |
|
| n-arylanthranilic acids (fenamates) | |
| COX-2 inhibitors (coxibs) | |
| other | |
| NSAID combinations | |
Key: underline indicates initially developed first-in-class compound of specific group; #WHO-Essential Medicines; †withdrawn drugs; ‡veterinary use. | |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.